Media and News
OMNIlife science, Inc. Announces PS Knee FDA Clearance
Orthopaedic Synergy, Inc. Announces Completion of PRAXIM, SA Acquisition
East Taunton, Mass., June 10, 2010 -- Orthopaedic Synergy, Inc., is pleased to announce that our acquisition of PRAXIM, SA, Grenoble, France was successfully completed on May 18, 2010.
Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA.
Press release, East Taunton, Mass., March 9, 2010
Orthopaedic Synergy, Inc., is pleased to announce that it has entered into a letter of intent and period of exclusivity to acquire Praxim, SA of France.
AMEDICA® SIGNS JOINT VENTURE AGREEMENT WITH ORTHOPAEDIC SYNERGY®
Press Release, Salt Lake City, February 23, 2010
Amedica Corporation (AC), a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today an agreement with Orthopaedic Synergy, Inc. (OSI) a holding company for OMNIlife Science™ and Enztec, both global designers, manufacturers and distributors of leading edge reconstructive surgery implants and instrumentation.
Joint venture opens doors to lucrative US market
The New Zealand Herald, New Zealand, April 2009
A New Zealand company could soon be designing custom hip and knee replacements for America's multibillion-dollar orthopaedic industry after joining forces with a United States firm.
Hip-horray as Enztec walks tall
The Press, New Zealand, March 2009
Recession or not, surgical instrument company Orthopaedic Synergy has raised US$6 million (NZ$10.3m) to expand its Christchurch business Enztec and increase staff by 15.
The replacement model
Unlimited Magazine, New Zealand, February 2009
Most Fast 50 companies think they're going to do better this year than the year before; it's in the nature of entrepreneurs to be eternally optimistic. But, in the case of Christchurch-based Enztec, ranked 27th on the 2008 Deloitte/Unlimited Fast50 for its 231.78% growth, a new business model could deliver on that positive thinking
State of the Art Technology Helps to Improve Surgical Outcomes
Bonezone Magazine, United States, January 2009
The importance of patient outcomes is the highest priority for surgeons when selecting the best course of action, and the best implant suitability for their patients. In complex cases such as tumor surgery where large bone mass needs to be removed, or for trauma cases where there is significant damage to the bone, the decision of what will best suit the patient can be a difficult one, as off the shelf implants do not always offer the best solution.
Series A Financing Completed for Two Orthopaedic Industry Innovators
Press Release, Raynham, Massachusetts, USA, January 2009
The Boards of Directors for OMNI life science Inc and Enztec Ltd are pleased to announce an initial close of US$4.8 million in the Series A financing, and the reorganization of their companies into holding company Orthopaedic Synergy, Inc (OSI).
Enztec joins forces with Omni Life Science (USA) to form Orthopaedic Synergy
Press Release, Christchurch, New Zealand, October 2008
Enztec joins forces with OMNI life science (USA) to form Orthopaedic Synergy - New Zealand's first majority owned orthopaedic organisation.
Hip Joint Venture Ignores Recession
The Dominion Post, New Zealand, October 2008
Christchurch-based Enztec and US based OMNI life science have set their sights on a public listing of the new company, Orthopaedic Synergy Inc, as it grows.